Erythromycin estolate
Erythromycin estolate is an orally bioavailable macrolide antibiotic that inhibits bacterial protein synthesis, used in research for susceptible respiratory and skin infections. Studies employ it in both in vitro susceptibility assays and in vivo infection models, noting its potential hepatotoxicity including cholestatic injury.
Product Specifications
CAS Number
3521-62-8
Product Name Alternative
Ilosone, Erythromycin estolate, Bacterial, Phtalic anhydride
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery
Purity
99.59% (May vary between batches)
Solubility
DMSO:45 mg/mL (42.6 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (1.89 mM)
Smiles
CCCCCCCCCCCCOS (O) (=O) =O.CCC1OC (=O) C (C) C (OC2CC (C) (OC) C (O) C (C) O2) C (C) C (OC2OC (C) CC (C2OC (=O) CC) N (C) C) C (C) (O) CC (C) C (=O) C (C) C (O) C1 (C) O
Molecular Formula
C52H97NO18S
Molecular Weight
1056.39
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
043435-HRP 200 µL
TTL, CT (TTL, Tubulin-tyrosine ligase) (Azide free) (HRP) discontinued
Sign In for Pricing
View Details 
MBS1391634-01 0.02 mg (E-Coli)
Recombinant Burkholderia thailandensis ATP synthase subunit beta 1 (atpD1)
Sign In for Pricing
View Details MBS1391634-02 0.02 mg (Yeast)
Recombinant Burkholderia thailandensis ATP synthase subunit beta 1 (atpD1)
Sign In for Pricing
View Details